Ultrasound Breaks Down Influenza and COVID-19 Viruses in Lab Study

By VirentaNews Staff — May 07, 2026

In a dimly lit laboratory at Arizona State University, rows of petri dishes sit beneath compact ultrasound emitters, humming at frequencies beyond human hearing. Inside these dishes, a silent battle unfolds: microscopic viral particles of influenza A and SARS-CoV-2—responsible for seasonal flu and the global pandemic—are being torn apart by invisible sound waves. Unlike traditional antiviral drugs or vaccines, this approach doesn’t rely on biochemistry or immune activation. Instead, it uses precise vibrations to exploit a fundamental weakness in the virus’s architecture. The result is startling: within minutes, the viruses collapse, their outer shells fractured and their ability to infect obliterated—all while nearby human cells remain unharmed. This is the quiet dawn of a new kind of medicine, where sound, not chemicals, becomes the scalpel.

Virus Inactivation Through Acoustic Resonance

Researchers have demonstrated that low-intensity ultrasound waves, tuned to specific frequencies between 20 and 30 megahertz, can selectively disrupt the structural integrity of enveloped viruses like influenza A and SARS-CoV-2. The technique hinges on a physical principle known as acoustic resonance, in which the natural vibrational frequency of the viral capsid or envelope matches the frequency of the incoming sound waves. When this match occurs, oscillations amplify within the virus particle, leading to mechanical stress, deformation, and ultimately rupture. In controlled experiments, exposure to these frequencies for just five minutes led to a significant reduction in viral load—up to 90% inactivated—without detectable damage to surrounding human epithelial cells. Crucially, the ultrasound parameters were optimized to target the unique size, shape, and stiffness of viral particles, sparing larger, more resilient human cells. This selectivity opens the door to non-invasive, localized treatments for respiratory infections, potentially administered via inhalers or nasal devices.

The Physics Behind the Breakthrough

The concept of using sound to manipulate biological matter is not new—ultrasound has long been employed in medical imaging and lithotripsy, where shock waves break kidney stones. However, applying it to viruses represents a leap in precision. The breakthrough emerged from a deeper understanding of viral biophysics: researchers used computational models to calculate the resonant frequencies of various pathogens, factoring in membrane thickness, diameter, and elasticity. For influenza A and SARS-CoV-2, both of which possess lipid envelopes studded with glycoproteins, the calculations predicted vulnerability in the 20–30 MHz range. Experiments confirmed these predictions, showing visible fragmentation of viral particles under electron microscopy after ultrasound exposure. The work, published in Scientific Reports, builds on earlier studies that used similar principles to target bacteriophages and herpesviruses. Now, researchers are mapping the resonant signatures of other pathogens, from RSV to Ebola, raising the possibility of a tunable, broad-spectrum antiviral platform.

The Scientists Behind the Sound

Leading the research is Dr. Mai Lu, a bioengineer at Arizona State’s Biodesign Institute, whose background in nanomechanics and acoustics positioned her to explore this unconventional intersection. Working alongside virologist Dr. Timothy Long, the team combined expertise in physical modeling and viral culture to design experiments that isolated the mechanical effects of ultrasound from thermal or chemical artifacts. Their motivation stemmed from the limitations of current antiviral therapies, which often face issues of resistance, narrow specificity, and systemic side effects. “We wanted to find a way to disable viruses without triggering evolutionary countermeasures,” Lu explained in a recent interview. “Viruses can mutate around drugs, but they can’t easily change their physical dimensions.” This insight drove the focus on mechanical vulnerability—a trait that is constrained by structural necessity. The team’s interdisciplinary approach, blending physics, engineering, and virology, exemplifies a growing trend in biomedical innovation where non-traditional tools are reimagined for therapeutic use.

What This Means for Medicine

If validated in animal models and eventually human trials, this technology could revolutionize how we treat viral infections—particularly in the respiratory tract. Imagine a handheld device that delivers targeted ultrasound through the nasal passages, inactivating viruses before they establish a foothold. Such a tool could serve as both a preventive measure during outbreaks and an early intervention for infected individuals. Unlike vaccines, it wouldn’t require immune activation, making it potentially useful for immunocompromised patients. It could also complement existing treatments, reducing viral shedding and transmission. However, significant challenges remain: ensuring precise delivery, avoiding off-target effects in complex tissues, and scaling the technology for clinical use. Regulatory pathways for physical, rather than pharmaceutical, interventions are less established, adding another layer of complexity. Still, the potential to create a modality that is drug-free, resistance-proof, and rapidly deployable is compelling.

The Bigger Picture

This research signals a paradigm shift in antiviral strategy—one that moves beyond biochemistry to exploit the physical laws governing life at the nanoscale. As antibiotic and antiviral resistance continue to rise, the need for alternative approaches has never been more urgent. By treating viruses as physical objects with quantifiable mechanical properties, scientists open a new front in the fight against infectious disease. The implications extend beyond respiratory viruses; if resonance-based inactivation works for other enveloped pathogens, it could be adapted for use in blood products, medical equipment, or even public spaces. This is not science fiction, but a growing field known as mechanomedicine, where physical forces become therapeutic agents.

What comes next is rigorous testing in living organisms, followed by device development and safety trials. While it may be years before ultrasound-based antiviral tools reach clinics, the principle has been proven: sound can dismantle viruses with surgical precision. As researchers refine frequencies for other pathogens and explore delivery mechanisms, the dream of a universal, non-invasive antiviral treatment grows closer. In the quiet hum of a laboratory, a new kind of healing may already be resonating.

Source: Agencia